RhumbLine Advisers’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $53K | Sell |
|
|||||
|
2024
Q4 | $246K | Buy |
|
|||||
|
2024
Q3 | $315K | Sell |
|
|||||
|
2024
Q2 | $354K | Sell |
|
|||||
|
2024
Q1 | $802K | Buy |
|
|||||
|
2023
Q4 | $371K | Hold |
|
|||||
|
2023
Q3 | $203K | Sell |
|
|||||
|
2023
Q2 | $542K | Buy |
|
|||||
|
2023
Q1 | $651K | Buy |
|
|||||
|
2022
Q4 | $896K | Buy |
|
|||||
|
2022
Q3 | $998K | Buy |
|
|||||
|
2022
Q2 | $626K | Buy |
|
|||||
|
2022
Q1 | $319K | Sell |
|
|||||
|
2021
Q4 | $502K | Sell |
|
|||||
|
2021
Q3 | $780K | Buy |
|
|||||
|
2021
Q2 | $1.09M | Buy |
|
|||||
|
2021
Q1 | $1.1M | Sell |
|
|||||
|
2020
Q4 | $1.86M | Buy |
|
|||||
|
2020
Q3 | $1.2M | Sell |
|
|||||
|
2020
Q2 | $1.62M | Buy |
|
|||||
|
2020
Q1 | $310K | Buy |
|
|||||
|
2019
Q4 | $266K | Buy |
|
|||||
|
2019
Q3 | $69K | Buy |
|
|||||
|
2019
Q2 | $160K | Buy |
|
|||||
|
2019
Q1 | $88K | Buy |
|
|||||
|
2018
Q4 | $66K | Buy |
|
|||||
|
2018
Q3 | $110K | Sell |
|
|||||
|
2018
Q2 | $211K | Buy |
|